Brind.

Natera received an Outperform rating from Evercore ISI on July 31, 2025.

1 report, 1 independent Updated Jul 31

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Natera

Keep exploring

The entities involved

Natera
company in San Carlos, United States
- Natera and Fractyl Health, biotech companies, traded on the NASDAQ stock exchange on September 1, 2026.Mon 02:47
- Natera's Signatera test is undergoing a Phase III trial across US sites, sponsored by NRG Oncology, while facing patent litigation.Sun 02:44

Coverage

Newest first; wire copies grouped

Jul 31Insider MonkeyEvercore ISI Initiates Coverage on Natera (NTRA) with Outperform Rating Natera, Inc. (NASDAQ:NTRA) is one of the high growth stocks outside tech analysts are bullish on. Evercore ISI Group has initia